Time for a strategic research response to anal cancer

Sexual Health

Volumn 9, Issue 6, 2012, Pages 628-631

  Grulich, Andrew E ^a   Hillman, Richard ^a,b   Brotherton, Julia M L ^c,d   Fairley, Christopher K ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VICTORIAN CYTOLOGY SERVICE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

Author keywords

human papillomavirus; incidence; prevalence; prevention; screening; treatment.

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; ANUS CARCINOMA; CANCER INCIDENCE; CANCER SCREENING; COLPOSCOPY; HIGH GRADE ANAL INTRAEPITHELIAL NEOPLASIA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MALE HOMOSEXUAL; PRIMARY PREVENTION; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; SECONDARY PREVENTION; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADENOCARCINOMA; ADULT; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CAUSALITY; COMORBIDITY; FEMALE; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; RISK-TAKING; SEXUALITY; UNITED STATES; WORLD HEALTH;

EID: 84870410689     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH12116     Document Type: Review

References (32)

1. Machalek DA, Grulich AE, Jin F, Templeton DJ, Poynten IM. The epidemiology and natural history of anal HPV infection in men who have sex with men. Sex Health 2012; 9(6): 527-537.
2. Machalek DA, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, et al. Anal human papillomavirus infection, and associated neoplastic lesions in homosexual men: systematic review and metaanalysis. Lancet Oncol 2012; 13: 487-500. doi:10.1016/S1470-2045 (12)70080-3
3. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study. J Infect Dis 2008; 197(7): 957-66. doi:10.1086/529207
4. Nyitray AG. The epidemiology of anal human papillomavirus infection among women and men having sex with women. Sex Health 2012; 9(6): 538-546. doi:10.1071/SH12021
5. Richters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: autoerotic, esoteric and other sexual practices engaged in by a representative sample of adults. Aust N Z J Public Health 2003; 27(2): 180-90. doi:10.1111/j.1467-842X.2003.tb00806.x
6. Jin F, Prestage GP, Kippax SC, Pell CM, Donovan B, Templeton DJ, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis 2007; 34(7): 488-93.
7. Coutlée F, de Pokomandy A, Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sex Health 2012; 9(6): 547-555.
8. Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sex Health 2012; 9(6): 504-508. doi:10.1071/SH12070
9. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365(17): 1576-85. doi:10.1056/NEJMoa1010971
10. Kreimer AR, Gonzalez P, Katki HA, Porras C, Schiffman M, Rodriguez AC, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica vaccine trial. Lancet Oncol 2011; 12(9): 862-70. doi:10.1016/S1470-2045(11)70213-3
11. Department of Health and Ageing (DoHA). Immunise Australia program. Canberra: DoHA; 2012. Available online at: www.immunise.health.gov.au [verified July 2012].
12. Dunne EFML, Chesson H, Curtis CR, Saraiya M, Gee J, Unger ER. Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60: 1705-8.
13. Palefsky JM, Holly EA, HogeboomCJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14(5): 415-22. doi:10.1097/00042560- 199704150-00004
14. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009; 113(1): 18-25.
15. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9(5): 425-34. doi:10.1016/S1470- 2045(08)70103-7
16. Roberts JM, Thurloe JK. Comparison of the performance of anal cytology and cervical cytology as screening tests. Sex Health 2012; 9(6): 568-573. doi:10.1071/SH11178
17. Palefsky JM. Practicing high-resolution anoscopy. Sex Health 2012; 9(6): 580-586.
18. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 2007; 197(4): 356e1-6. doi:10.1016/j.ajog.2007.07.049
19. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007; 197(4): 340-5. doi:10.1016/ j.ajog.2007.07.050
20. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007; 11(4): 223-39. doi:10.1097/ LGT.0b013e318159408b
21. Poynten IM, Templeton DJ, Grulich AE. Sexually transmissible infections in aging HIV populations. Sex Health 2011; 8(4): 508-11. doi:10.1071/SH11027
22. Fox PA. Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness. Sex Health 2012; 9(6): 587-592. doi:10.1071/SH11157
23. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367(9509): 489-98. doi:10.1016/ S0140-6736(06)68181- 6
24. Chamot E, Kristensen S, Stringer JS, Mwanahamuntu MH. Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review. BMC Womens Health 2010; 10: 11. doi:10.1186/1472-6874-10-11
25. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(4): 1-207.
26. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol 2010; 37(3): 202-15. doi:10.1053/j.seminoncol.2010.05.006
27. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst 1980; 64(5): 1263-72.
28. Smith DP, Supramaniam R, Marshall VR, Armstrong BK. Prostate cancer and prostate-specific antigen testing in New South Wales. Med J Aust 2008; 189(6): 315-8.
29. Hoffman RM. Randomized trial results did not resolve controversies surrounding prostate cancer screening. Curr Opin Urol 2010; 20(3): 189-93. doi:10.1097/MOU.0b013e3283383b55
30. Brawley OW. Prostate cancer screening; is this a teachable moment? J Natl Cancer Inst 2009; 101(19): 1295-7. doi:10.1093/jnci/djp310
31. Moyer VA. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-34.
32. Howard K. The cost-effectiveness of screening for anal cancer in men who have sex with men: a systematic review. Sex Health 2012; 9(6): 610-619. doi:10.1071/SH12017